Clincosm LogoSign in Get a demo

Neoplasm Malignant

Showing NaN - NaN of 7
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Tumor Malignant, Renal Cell Carcinoma, Hormone Receptor Positive Breast Carcinoma Trial in Worldwide (XL092, Atezolizumab,

Recruiting
  • Neoplasm Malignant
  • +5 more
  • Duarte, California
  • +55 more
Aug 17, 2022

Tumor Malignant, Epithelial Ovarian Cancer, Triple Negative Breast Cancer Trial in United States (XL102, Fulvestrant,

Recruiting
  • Neoplasm Malignant
  • +4 more
  • Atlanta, Georgia
  • +4 more
Apr 19, 2022

Tumor Malignant Trial in Worldwide (SAR245408, SAR245409)

Completed
Has Results
  • Neoplasm Malignant
  • Birmingham, Alabama
  • +20 more
Mar 30, 2022

Advanced Cancer, Ovarian Cancer, Breast Cancer Trial in United States (COM701, COM701 with Opdivo (Nivolumab).)

Recruiting
  • Advanced Cancer
  • +9 more
  • COM701
  • COM701 with Opdivo (Nivolumab).
  • Los Angeles, California
  • +10 more
Jan 25, 2022

Tumor Malignant Trial in France, Netherlands, United States (SAR405838)

Completed
  • Neoplasm Malignant
  • Boston, Massachusetts
  • +6 more
May 16, 2018

Tumor Malignant Trial in United States (Cabazitaxel (XRP6258))

Completed
  • Neoplasm Malignant
  • Cabazitaxel (XRP6258)
  • La Jolla, California
  • +13 more
Jul 20, 2015

Tumor Malignant Trial in Boston, Houston, Toronto (SAR260301, Vemurafenib)

Completed
  • Neoplasm Malignant
  • Boston, Massachusetts
  • +3 more
Apr 9, 2015